The effect of erbium laser in striae

Phase 2

Recruiting

• Conditions: striae distensae.; L90.6; Striae atrophicae

• Registration Number: IRCT20220322054341N2
• Lead Sponsor: Skin and Stem Cell Research Center of Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

The diagnosis of stria distensa based on the diagnosis of a dermatologist
Age less than 50 years and more than 18 years

Exclusion Criteria

Using any treatment method to remove striae in the last three months
Presence of lesions and skin diseases such as skin cancer or infections
Presence of collagen vascular diseases
Pregnancy and lactation
Using steroids or immunosuppressive drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pigmentation (color of the lesion). Timepoint: 3 months after the treatment. Method of measurement: Biometry with Colorimeter 4000, Multi Probe Adaptor System 5 (MPA5).;Elasticity of the skin. Timepoint: 3 months after the treatment. Method of measurement: Biometry with Cutometer, Multi Probe Adaptor System 580 (MPA580).

Secondary Outcome Measures

Name	Time	Method
Patient satisfaction. Timepoint: 3 months after the treatment. Method of measurement: Based on patient global assessment score.;Complications. Timepoint: 3 months after the treatment. Method of measurement: Using a checklist containing treatment complications including pain, erythema and edema.